Does duloxetine improve cognitive function independently of its antidepressant effect in patients with major depressive disorder and subjective reports of cognitive dysfunction?

Depression Research and Treatment

Volumn 2014, Issue , 2014, Pages

  Greer, Tracy L ^a   Sunderajan, Prabha ^a   Grannemann, Bruce D ^a   Kurian, Benji T ^a   Trivedi, Madhukar H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893662380     PISSN: 20901321     EISSN: 2090133X     Source Type: Journal    
DOI: 10.1155/2014/627863     Document Type: Article

References (52)

1. Veiel H. O. F., A preliminary profile of neuropsychological deficits associated with major depression. Journal of Clinical and Experimental Neuropsychology 1997 19 4 587 603 2-s2.0-0030800440 (Pubitemid 27452012)
2. Elliot R., Executive functions and their disorders. British Medical Bulletin 2003 65 1 49 59 10.1093/bmb/65.1.49 (Pubitemid 36406457)
3. Landrø N. I., Stiles T. C., Sletvold H., Neuropsychological function in nonpsychotic unipolar major depression. Neuropsychiatry, Neuropsychology and Behavioral Neurology 2001 14 4 233 240 2-s2.0-0035153548 (Pubitemid 33051500)
4. Sobin C., Sackeim H. A., Psychomotor symptoms of depression. American Journal of Psychiatry 1997 154 1 4 17 2-s2.0-0031016615 (Pubitemid 27020186)
5. Butters M. A., Whyte E. M., Nebes R. D., Begley A. E., Dew M. A., Mulsant B. H., Zmuda M. D., Bhalla R., Meltzer C. C., Pollock B. G., Reynolds C. F. III, Becker J. T., The nature and determinants of neuropsychological functioning in late-life depression. Archives of General Psychiatry 2004 61 6 587 595 2-s2.0-2942592733 10.1001/archpsyc.61.6.587 (Pubitemid 38747313)
6. Judd L. L., Akiskal H. S., Zeller P. J., Paulus M., Leon A. C., Maser J. D., Endicott J., Coryell W., Kunovac J. L., Mueller T. I., Rice J. P., Keller M. B., Psychosocial disability during the long-term course of unipolar major depressive disorder. Archives of General Psychiatry 2000 57 4 375 380 2-s2.0-0034091171 (Pubitemid 30202328)
7. Judd L. L., Schettler P. J., Solomon D. A., Maser J. D., Coryell W., Endicott J., Akiskal H. S., Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders. Journal of Affective Disorders 2008 108 1-2 49 58 2-s2.0-40949151451 10.1016/j.jad.2007.06.014 (Pubitemid 351418013)
8. Bromet E., Andrade L. H., Hwang I., Sampson N. A., Alonso J., de Girolamo G., de Graaf R., Demyttenaere K., Hu C., Iwata N., Karam A. N., Kaur J., Kostyuchenko S., Lépine J. P., Levinson D., Matschinger H., Mora M. E. M., Browne M. O., Posada-Villa J., Viana M. C., Williams D. R., Kessler R. C., Cross-national epidemiology of DSM-IV major depressive episode. BMC Medicine 2011 9 article 90 2-s2.0-79960659664 10.1186/1741-7015-9-90
9. Kessler R. C., Akiskal H. S., Ames M., Birnbaum H., Greenberg P., Hirschfeld R. M. A., Jin R., Merikangas K. R., Simon G. E., Wang P. S., Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. American Journal of Psychiatry 2006 163 9 1561 1568 2-s2.0-33749057523 10.1176/appi.ajp.163.9.1561 (Pubitemid 44465756)
10. Merikangas K. R., Ames M., Cui L., Stang P. E., Ustun T. B., Von Korff M., Kessler R. C., The impact of comorbidity of mental and physical conditions on role disability in the US adult household population. Archives of General Psychiatry 2007 64 10 1180 1188 2-s2.0-34948893852 10.1001/archpsyc.64.10.1180 (Pubitemid 47529342)
11. Jaeger J., Berns S., Uzelac S., Davis-Conway S., Neurocognitive deficits and disability in major depressive disorder. Psychiatry Research 2006 145 1 39 48 2-s2.0-33750690680 10.1016/j.psychres.2005.11.011 (Pubitemid 44709192)
12. Trivedi M. H., Morris D. W., Wisniewski S. R., Lesser I., Nierenberg A. A., Daly E., Kurian B. T., Gaynes B. N., Balasubramani G. K., Rush A. J., Increase in work productivity of depressed individuals with improvement in depressive symptom severity. American Journal of Psychiatry 2013 170 6 633 641 10.1176/appi.ajp.2012.12020250
13. McIntosh B. J., Zhang X. Y., Kosten T., Tan S. P., Xiu M. H., Rakofsky J., Harvey P. D., Performance-based assessment of functional skills in severe mental illness: results of a large-scale study in China. Journal of Psychiatric Research 2011 45 8 1089 1094 2-s2.0-79960600322 10.1016/j.jpsychires.2011.01.012
14. Cassano G. B., Puca F., Scapicchio P. L., Trabucchi M., Aguglia E., Albano C., Bruzzone G., Antico L., Guidi L., Tricerfi A., Cappa C., Smerieri G., Cassano G. B., Simonini E., Tilli C., Caserta F., Varia S., Cerqua R., Califano M., Cerqua G., Chioma V., Bertuzzi D., Menetti M., Corsonello F., Zottola C., Pranno L., De Candia R., Di Fiorino M., Cerfi A., Bani A., Fichera G., Bonomol G., Giberti G., Cassis S., Grumelli B., Galetti G., Anni G., Guala A., Lancia U., Saponaro A., Longobardi L., Bruni A., Macchione C., Fantò F., Baietto T., Martucci M., Faronl J., Calandriello L., Meduri M., Di Rosa A. E., Cacciola M., Mordechai M., Zuccaro S. M., Palummeri E., Cella A., Trasciatti S., Paolucci S., Coiro R., Pedone V., Angelini A., Piani F., Righini D., Puca E., Brancasi B., Rengo F., Abete P., Cacciatore F., Robotti C. A., Bilone F. B. F., Nicotra M. C., Rotolo V., Salsi A., De Carolis S., Scarpino O., Del Gobbo M., Sdanganelli F., Di Biase A., Pontrelli B., Spilimbergo P. G., Di Costanzo E., Matranga M., Stocchi E., Grassini P., Valenti G., Fontana V., Venuta M., Guaraldi G. P., Zanni L., Verrienti P., Stoppelli N., Scardino V., Vischia F., Pirfo E., Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients. Journal of Clinical Psychiatry 2002 63 5 396 402 2-s2.0-0036252382 (Pubitemid 34507216)
15. Gallassi R., Di Sarro R., Morreale A., Amore M., Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy. Journal of Affective Disorders 2006 91 2-3 243 250 2-s2.0-33644998293 10.1016/j.jad.2006.01.018
16. Raskin J., Wiltse C. G., Siegal A., Sheikh J., Xu J., Dinkel J. J., Rotz B. T., Mohs R. C., Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. American Journal of Psychiatry 2007 164 6 900 909 2-s2.0-34250832737 10.1176/appi.ajp.164.6.900 (Pubitemid 46972905)
17. Levkovitz Y., Caftori R., Avital A., Richter-Levin G., The SSRIs drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression. Brain Research Bulletin 2002 58 4 345 350 2-s2.0-0035993389 10.1016/S0361-9230(01)00780-8
18. Richardson J. S., Keegan D. L., Bowen R. C., Blackshaw S. L., Cebrian-Perez S., Dayal N., Saleh S., Shrikhande S., Verbal learning by major depressive disorder patients during treatment with fluoxetine or amitriptyline. International Clinical Psychopharmacology 1994 9 1 35 40 2-s2.0-0028107268 (Pubitemid 24062650)
19. Fava M., Graves L. M., Benazzi F., Scalia M. J., Iosifescu D. V., Alpert J. E., Papakostas G. I., A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. Journal of Clinical Psychiatry 2006 67 11 1754 1759 2-s2.0-33845617627 (Pubitemid 44955157)
20. Gualtieri C. T., Johnson L. G., Benedict K. B., Neurocognition in depression: patients on and off medication versus healthy comparison subjects. Journal of Neuropsychiatry and Clinical Neurosciences 2006 18 2 217 225 2-s2.0-33646723544 10.1176/appi.neuropsych.18.2.217
21. Hammar Å., Lund A., Hugdahl K., Long-lasting cognitive impairment in unipolar major depression: a 6-month follow-up study. Psychiatry Research 2003 118 2 189 196 2-s2.0-0038207051 10.1016/S0165-1781(03)00075-1 (Pubitemid 36694433)
22. Weiland-Fiedler P., Erickson K., Waldeck T., Luckenbaugh D. A., Pike D., Bonne O., Charney D. S., Neumeister A., Evidence for continuing neuropsychological impairments in depression. Journal of Affective Disorders 2004 82 2 253 258 2-s2.0-5644246458 10.1016/j.jad.2003.10.009 (Pubitemid 39370827)
23. Smith D. J., Muir W. J., Blackwood D. H. R., Neurocognitive impairment in euthymic young adults with bipolar spectrum disorder and recurrent major depressive disorder. Bipolar Disorders 2006 8 1 40 46 2-s2.0-33644816665 10.1111/j.1399-5618.2006.00275.x (Pubitemid 43356019)
24. Paelecke-Habermann Y., Pohl J., Leplow B., Attention and executive functions in remitted major depression patients. Journal of Affective Disorders 2005 89 1-3 125 135 2-s2.0-28444458831 10.1016/j.jad.2005.09.006 (Pubitemid 41740840)
25. Kurian B. T., Greer T. L., Trivedi M. H., Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms. Expert Review of Neurotherapeutics 2009 9 7 975 984 2-s2.0-67651030466 10.1586/ern.09.53
26. Judd L. L., Paulus M. J., Schettler P. J., Akiskal H. S., Endicott J., Leon A. C., Maser J. D., Mueller T., Solomon D. A., Keller M. B., Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? American Journal of Psychiatry 2000 157 9 1501 1504 2-s2.0-0033850307 10.1176/appi.ajp.157.9.1501
27. Greer T. L., Kurian B. T., Trivedi M. H., Defining and measuring functional recovery from depression. CNS Drugs 2010 24 4 267 284 2-s2.0-77949761571 10.2165/11530230-000000000-00000
28. Detke M. J., Lu Y., Goldstein D. J., Hayes J. R., Demitrack M. A., Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. Journal of Clinical Psychiatry 2002 63 4 308 315 2-s2.0-0036232639 (Pubitemid 34456358)
29. Goldstein D. J., Mallinckrodt C., Lu Y., Demitrack M. A., Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial. Journal of Clinical Psychiatry 2002 63 3 225 231 2-s2.0-0036112313 (Pubitemid 34407082)
30. Schatzberg A. F., Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder. Journal of Clinical Psychiatry 2003 64 13 30 37 2-s2.0-0142043025 (Pubitemid 37267813)
31. Kihara T., Ikeda M., Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex. Journal of Pharmacology and Experimental Therapeutics 1995 272 1 177 183 2-s2.0-0028855727
32. Trivedi M. H., Desaiah D., Ossanna M. J., Pritchett Y. L., Brannan S. K., Detke M. J., Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine. International Clinical Psychopharmacology 2008 23 3 161 169 2-s2.0-42149114016 10.1097/YIC.0b013e3282f41d7e (Pubitemid 351535907)
33. Arnsten A. F. T., Catecholamine influences on dorsolateral prefrontal cortical networks. Biological Psychiatry 2011 69 12 e89 e99 2-s2.0-79958143939 10.1016/j.biopsych.2011.01.027
34. Stahl S. M., Norepinephrine and dopamine regulate signals and noise in the prefrontal cortex. Journal of Clinical Psychiatry 2009 70 5 617 618 2-s2.0-67049109715 10.4088/JCP.09bs05143
35. Herrera-Guzmán I., Gudayol-Ferré E., Herrera-Guzmán D., Guàrdia-Olmos J., Hinojosa-Calvo E., Herrera-Abarca J. E., Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. Journal of Psychiatric Research 2009 43 9 855 863 2-s2.0-67349138171 10.1016/j.jpsychires.2008.10.015
36. Herrera-Guzmán I., Herrera-Abarca J. E., Gudayol-Ferré E., Herrera-Guzmán D., Gómez-Carbajal L., Peña-Olvira M., Villuendas-González E., Joan G. O., Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder. Psychiatry Research 2010 177 3 323 329 2-s2.0-77952674864 10.1016/j.psychres.2010.03.006
37. McClintock S. M., Husain M. M., Greer T. L., Cullum C. M., Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. Neuropsychology 2010 24 1 9 34 2-s2.0-77949360302 10.1037/a0017336
38. Beblo T., Baumann B., Bogerts B., Wallesch C. W., Herrmann M., Neuropsychological correlates of major depression: a short-term follow-up. Cognitive Neuropsychiatry 1999 4 4 333 341 2-s2.0-0001688810
39. Biringer E., Lundervold A., Stordal K., Mykletun A., Egeland J., Bottlender R., Lund A., Executive function improvement upon remission of recurrent unipolar depression. European Archives of Psychiatry and Clinical Neuroscience 2005 255 6 373 380 2-s2.0-27944450607 10.1007/s00406-005-0577-7 (Pubitemid 43029826)
40. CANTABeclipse Test Administration Guide 2004 Cambridge Cognition Limited
41. Rush A. J., Giles D. E., Schlesser M. A. S., The inventory for depressive symptomatology (IDS): preliminary findings. Psychiatry Research 1986 18 1 65 87 2-s2.0-0022501599 (Pubitemid 16085767)
42. Hamilton M., A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 1960 23 56 62 2-s2.0-72949151592
43. Guy W., ECDEU Assessment Manual for Psychopharmacology 1976 revised (DHEW publication no. ADM 76-338) Washington, DC, USA U.S. Government Printing Office
44. Sackeim H. A., The definition and meaning of treatment-resistant depression. Journal of Clinical Psychiatry 2001 62 16 10 17 2-s2.0-0034934926
45. First M. B., Spitzer R. L., Gibbon M., Williams J. B. W., Structured Clinical Interview for DSM-IV Axis I Disorders Clinician Version (SCID-1-CV) 1995 New York, NY, USA Biometrics Research Department, New York State Psychiatric Institute, Department of Psychiatry, Columbia University
46. Blair J. R., Spreen O., Predicting premorbid IQ: a revision of the National Adult Reading Test. Clinical Neuropsychologist 1989 3 2 129 136 10.1080/13854048908403285
47. Sanislow C. A., Pine D. S., Quinn K. J., Kozak M. J., Garvey M. A., Heinssen R. K., Wang P. S. E., Cuthbert B. N., Developing constructs for psychopathology research: research domain criteria. Journal of Abnormal Psychology 2010 119 4 631 639 2-s2.0-78649712310 10.1037/a0020909
48. Insel T., Cuthbert B., Garvey M., Heinssen R., Pine D. S., Quinn K., Sanislow C., Wang P., Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. American Journal of Psychiatry 2010 167 7 748 751 2-s2.0-77954230363 10.1176/appi.ajp.2010.09091379
49. Trivedi M. H., Rush A. J., Wisniewski S. R., Nierenberg A. A., Warden D., Ritz L., Norquist G., Howland R. H., Lebowitz B., McGrath P. J., Shores-Wilson K., Biggs M. M., Balasubramani G. K., Fava M., Evaluation of outcomes with citalopram for depression using measurement-based care in STAR-D: implications for clinical practice. American Journal of Psychiatry 2006 163 1 28 40 2-s2.0-30044433660 10.1176/appi.ajp.163.1.28
50. Rush A. J., Fava M., Wisniewski S. R., Lavori P. W., Trivedi M. H., Sackeim H. A., Thase M. E., Nierenberg A. A., Quitkin F. M., Kashner T. M., Kupfer D. J., Rosenbaum J. F., Alpert J., Stewart J. W., McGrath P. J., Biggs M. M., Shores-Wilson K., Lebowitz B. D., Ritz L., Niederehe G., Sequenced treatment alternatives to relieve depression (STAR-D): rationale and design. Controlled Clinical Trials 2004 25 1 119 142 2-s2.0-10744220820 10.1016/S0197-2456(03)00112-0 (Pubitemid 38230109)
51. Wisniewski S. R., Rush A. J., Balasubramani G. K., Trivedi M. H., Nierenberg A. A., Self-rated global measure of the frequency, intensity, and burden of side effects. Journal of Psychiatric Practice 2006 12 2 71 79 2-s2.0-33745598890 10.1097/00131746-200603000-00002 (Pubitemid 44284089)
52. Cohen J., Cohen P., Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences 1983 2nd Hillsdale, NJ, USA Lawrence Erlbaum Associates